These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34637178)

  • 1. Low-dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients.
    Yin L; Svigos K; Gutierrez D; Peterson E; Lo Sicco K; Shapiro J
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e200-e202. PubMed ID: 34637178
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: A retrospective study.
    Ong M; Do H; Ho B; Lipner SR
    J Am Acad Dermatol; 2024 Feb; 90(2):425-427. PubMed ID: 37839733
    [No Abstract]   [Full Text] [Related]  

  • 3. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral minoxidil treatment for hair loss: A review of efficacy and safety.
    Randolph M; Tosti A
    J Am Acad Dermatol; 2021 Mar; 84(3):737-746. PubMed ID: 32622136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
    Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
    Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated hair growth by combining thread monofilament and minoxidil in female androgenetic alopecia.
    Khattab FM; Bessar H
    J Cosmet Dermatol; 2020 Jul; 19(7):1738-1744. PubMed ID: 31789457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia.
    Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y
    J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of oral minoxidil in female androgenetic alopecia.
    Vastarella M; Cantelli M; Patrì A; Annunziata MC; Nappa P; Fabbrocini G
    Dermatol Ther; 2020 Nov; 33(6):e14234. PubMed ID: 32851744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
    Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
    Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
    Roberts J; Desai N; McCoy J; Goren A
    Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights Into Perceptions and Gender Differences About Androgenetic Alopecia in an Observational Study of Commenters on the New York Times Oral Minoxidil Article.
    Desir N; Desai AD; Jafari A; Lipner SR
    J Cutan Med Surg; 2023; 27(4):399-400. PubMed ID: 37083142
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia.
    Goren A; Castano JA; McCoy J; Bermudez F; Lotti T
    Dermatol Ther; 2014; 27(3):171-3. PubMed ID: 24283387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.
    Barbareschi M
    G Ital Dermatol Venereol; 2018 Feb; 153(1):102-106. PubMed ID: 29319278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls.
    Olamiju B; Craiglow BG
    J Am Acad Dermatol; 2021 Jun; 84(6):1689-1691. PubMed ID: 33333154
    [No Abstract]   [Full Text] [Related]  

  • 20. Microneedling in androgenetic alopecia; comparing two different depths of microneedles.
    Faghihi G; Nabavinejad S; Mokhtari F; Fatemi Naeini F; Iraji F
    J Cosmet Dermatol; 2021 Apr; 20(4):1241-1247. PubMed ID: 32897622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.